SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCGT again
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Ucci who wrote (62)10/7/1996 2:29:00 PM
From: Stock Puppy   of 283
 
10 KSB on Edgar:
sec.gov

Year Ended June 30,
------------------------------
1996 1995
------------- ---------------
S> <C> <C>
REVENUES:
Net sales of third party software
and support services $ 723,964 $ 571,503
Net sales of medical products 6,068 1,144
Fees charged to medical providers 15,974 842
----------- ------------
TOTAL REVENUES 746,006 573,489

COSTS AND EXPENSES:
Cost of sales 328,560 222,205
Marketing, general and administrative 2,152,757 771,613
Depreciation and amortization 732,194 728,420
Interest 1,247 55
---------- -----------
TOTAL COSTS AND EXPENSES 3,214,758 1,722,293
---------- -----------
NET LOSS $(2,468,752) $(1,148,804)
=========== ===========
NET LOSS PER COMMON SHARE $ (.12) $ (.06)
=========== ===========
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING 21,226,848 19,092,084
=========== ===========
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News